EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Consortium for Clarity in ADRD Research Through Imaging (CLARiTI)

Elizabeth C Mormino iD, Sarah A Biber, Annalise Rahman-Filipiak, Konstantinos Arfanakis, Lindsay Clark, Jeffrey L Dage, John A Detre, Bradford C Dickerson, Michael C Donohue, Steven Kecskemeti, Timothy J Hohman, William J Jagust und 12 weitere

Alzheimer's & Dementia · 2025-01 · 21 (1)

DOI: 10.1002/alz.14383 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia, online erschienen am 26.11.2024. Verfasst von Elizabeth C Mormino und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Palo Alto, California, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Neuroimaging, Dementia, Brain. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The presence of multiple pathologies is the largest predictor of dementia. A major gap in the field is the in vivo detection of mixed pathologies and their antecedents. The Alzheimer's Disease Research Centers (ADRCs) are uniquely positioned to address this gap. The ADRCs longitudinally follow ≈ 17,000 participants, ranging from cognitively unimpaired to dementia, arising from Alzheimer's disease (AD) and related dementias (ADRD; e.g., AD, Lewy body disorders, vascular). Motivated by the Alzheimer's Disease Neuroimaging Initiative's (ADNI) impact, the ADRC Consortium for Clarity in ADRD Research Through Imaging (CLARiTI) was formed. Leveraging existing ADRC infrastructure, CLARiTI will integrate standardized imaging and plasma collection to characterize mixed pathologies and use community‐engaged research methods to ensure that ≥ 25% of the sample is from underrepresented populations (e.g., ethnoculturally minoritized, low education). The resulting ADRD profiles, within a more diverse sample, will provide key resources for ADRCs and an unprecedented, more generalizable publicly available imaging‐plasma dataset. Highlights In vivo detection of mixed pathologies is critical for Alzheimer's disease and related dementias research. The Alzheimer's Disease Research Centers (ADRCs) are uniquely positioned to address gaps related to mixed pathologies. The ADRC Consortium for Clarity in ADRD Research Through Imaging (CLARiTI) will enhance this national program by adding standardized imaging and plasma collection to existing ADRC infrastructure. This effort will provide key resources for ADRCs and an unprecedented publicly available imaging–plasma–neuropath dataset.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseNeuroimagingDementiaBrainHumansBiomedical ResearchLongitudinal Studies

Stichwörter der Autor:innen

Alzheimer's diseasebiomarkersmagnetic resonance imagingneuroimagingpathologyplasma markerspositron emission tomography

Autor:innen und Institutionen

  • Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Palo Alto, California, USA.
  • Wu Tsai Neurosciences Institute, Stanford University School of Medicine, Cogen Facility, Stanford, California, USA.
  • National Alzheimer's Coordinating Center, University of Washington, Seattle, Washington, USA.
  • Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA.
  • Department of Biomedical Engineering, Illinois Tech, Chicago, Illinois, USA.
  • Department of Medicine, University of Wisconsin School of Medicine and Public Health, Health Sciences Learning Center, Madison, Wisconsin, USA.

ORCID-Profile: Elizabeth C Mormino

Förderung

  • NIA NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Mormino, E. C., Biber, S. A., Rahman-Filipiak, A., Arfanakis, K., Clark, L., Dage, J. L., Detre, J. A., Dickerson, B. C., Donohue, M. C., Kecskemeti, S., Hohman, T. J., Jagust, W. J., Keene, D. C., Kukull, W., Levendovszky, S. R., Rosen, H., Thompson, P. M., Villemagne, V. L., Wolk, D. A., …, & Johnson, S. C. (2025). The Consortium for Clarity in ADRD Research Through Imaging (CLARiTI). Alzheimer's & Dementia, 21(1). https://doi.org/10.1002/alz.14383

Vancouver

Mormino EC, Biber SA, Rahman-Filipiak A, Arfanakis K, Clark L, Dage JL, et al. The Consortium for Clarity in ADRD Research Through Imaging (CLARiTI). Alzheimer's & Dementia. 2025;21(1). doi:10.1002/alz.14383

BibTeX
@article{Mormino2025,
  author = {Mormino, Elizabeth C and Biber, Sarah A and Rahman-Filipiak, Annalise and Arfanakis, Konstantinos and Clark, Lindsay and Dage, Jeffrey L and Detre, John A and Dickerson, Bradford C and Donohue, Michael C and Kecskemeti, Steven and Hohman, Timothy J and Jagust, William J and Keene, Dirk C and Kukull, Walter and Levendovszky, Swati R and Rosen, Howie and Thompson, Paul M and Villemagne, Victor L and Wolk, David A and Okonkwo, Ozioma C and Rabinvovici, Gil D and Rivera-Mindt, Monica and Foroud, Tatiana and Johnson, Sterling C},
  title = {The Consortium for Clarity in ADRD Research Through Imaging (CLARiTI)},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {1},
  doi = {10.1002/alz.14383}
}
Kostenlos starten →